RYAH Group Granted Patent to use Artificial Intelligence for Healthcare Cannabis Significant Information Processing

[ad_1]



NEW YORK, July 31, 2019 (GLOBE NEWSWIRE) — RYAH Group (“RYAH” or the “Organization”), an A.I., massive information and IoT device enterprise focused on plant-primarily based medicine dosing and analytics, now announced that it was granted a patent to make use of artificial intelligence for the evaluation of healthcare cannabis information.

With U.S. Patent # 10,296,714, “Method and program for healthcare cannabinoid therapy and item choice,” RYAH’s massive information platform will now use Artificial Intelligence (AI) to improved recognize and recognize correlations involving plant strains and healthcare indications. RYAH is at present processing 37 healthcare indications across healthcare databases and clinical trials. In addition, details collected from RYAH’s dose-measuring devices is stored in RYAH’s HIPAA compliant database and processed employing A.I. to create reality-primarily based choices. Healthcare specialists, marketers, dispensaries, and other healthcare cannabis stakeholders will be capable employ this database for study purposes, as it will function anonymous, true-time patients’ feedback and correct information.

“This patent is a further step in our lengthy-term approach to be a marketplace leader in building a useful, predictive, enterprise information analytics option in the healthcare plant market,” stated Gregory Wagner, CEO of RYAH. “We anticipate this patent to additional validate our expanding IoT item suite and open future healthcare and small business possibilities that enable specialists to make informed choices from true time strain-associated usage information. This patent eventually confirms our dedication in employing artificial intelligence and massive information to potentially modify lives”

Investigation suggests that the prescription / recommendation method for healthcare cannabis and associated merchandise requires to be far more effective and far more informative. RYAH’s information platform will use the most recent technologies, such as AI, to streamline recommendation and prescription choice creating method for each healthcare specialists and shoppers. It is believed that the database will turn out to be an desirable function for a wide variety of prospective partners and collaborators, particularly considering the fact that the cannabis marketplace is shifting to information driven choice creating. RYAH also has plans to expand to use its AI, massive-information platform and IoT options into the increasing nutraceutical marketplace.

About RYAH Medtech, Inc.

RYAH is a massive information and technologies enterprise focused on beneficial predictive evaluation in the international healthcare plant intake market. Its robust artificial intelligence platform aggregates and correlates HIPAA-compliant healthcare information, which is intended to assistance medical doctors and sufferers personalize plant-primarily based therapies to improved predict therapy outcomes. The information collection is also relevant for growers, dispensaries and Licensed Processors (LPs) to monitor and handle plant strain effects on sufferers. With a sturdy IP portfolio, RYAH gathers deep and insightful information on the comprehensive healthcare plant lifecycle, from seed to consumption.

Forward-Hunting Statements

Specific statements contained in this press release constitute “forward-seeking information” as such term is defined in applicable Canadian securities legislation and United States guidelines and regulation. The words “may”, “would”, “could”, “should”, “potential”, “will”, “seek”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and equivalent expressions as they relate to the Organization, execution of added distribution agreements and the benefits customers could obtain from employing RYAH are intended to recognize forward-seeking details. All statements other than statements of historical reality could be forward-seeking details. Such statements reflect the Company’s existing views and intentions with respect to future events, and existing details readily available to the Organization, and are topic to specific dangers, uncertainties and assumptions. Several things could result in the actual benefits, functionality or achievements that could be expressed or implied by such forward-seeking details to differ from these described herein should really 1 or far more of these dangers or uncertainties materialize. These things consist of, with no limitation: the common small business and financial situations in the regions in which the Organization operates the capacity of the Organization to execute on important priorities, such as the prosperous completion of acquisitions, small business retention, and strategic plans and to attract, create and retain important executives difficulty integrating newly acquired companies the capacity to implement small business methods and pursue small business possibilities disruptions in or attacks (such as cyber-attacks) on the Company’s details technologies, online, network access or other voice or information communications systems or solutions the evolution of a variety of varieties of fraud or other criminal behavior to which the Organization is exposed the failure of third parties to comply with their obligations to the Organization or its affiliates the influence of new and adjustments to, or application of, existing laws and regulations a novel small business model granting of permits and licenses in a hugely regulated small business the all round hard litigation atmosphere, such as in the United States improved competitors adjustments in foreign currency prices improved funding charges and marketplace volatility due to marketplace illiquidity and competitors for funding the availability of funds and sources to pursue operations essential accounting estimates and adjustments to accounting requirements, policies, and procedures made use of by the Organization the occurrence of organic and unnatural catastrophic events and claims resulting from such events and the danger related with a small business in the cannabis market. Should really any issue influence the Organization in an unexpected manner, or should really assumptions underlying the forward-seeking details prove incorrect, the actual benefits or events could differ materially from the benefits or events predicted. Any such forward-seeking details is expressly certified in its entirety by this cautionary statement. Furthermore, the Organization does not assume duty for the accuracy or completeness of such forward-seeking details. The forward-seeking details incorporated in this press release is produced as of the date of this press release and the Organization undertakes no obligation to publicly update or revise any forward-seeking details, other than as expected by applicable law.

Make contact with
[email protected]
1.917.525.2697

About Ryan Allway

Mr. Allway has more than a decade of practical experience in the economic markets as each a private investor and economic journalist. He has been actively involved in the cannabis market considering the fact that its inception, covering public and private providers.




[ad_2]

Latest posts